Viewing Study NCT02262533


Ignite Creation Date: 2025-12-25 @ 2:55 AM
Ignite Modification Date: 2026-02-25 @ 10:04 PM
Study NCT ID: NCT02262533
Status: COMPLETED
Last Update Posted: 2015-08-10
First Post: 2014-10-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Drug Interaction Study of Apixaban and Atenolol in Healthy Subjects
Sponsor: Bristol-Myers Squibb
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-06
Start Date Type: None
Primary Completion Date: 2007-06
Primary Completion Date Type: ACTUAL
Completion Date: 2007-06
Completion Date Type: ACTUAL
First Submit Date: 2014-10-09
First Submit QC Date: None
Study First Post Date: 2014-10-13
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2015-08-06
Last Update Post Date: 2015-08-10
Last Update Post Date Type: ESTIMATED